Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporary basis: RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled syringe (Roche Germany) RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled pen (Roche Germany) These products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 1

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporary basis: RoActemra tocilizumab 80 mg/4 mL concentrate for solution for infusion (Roche Germany) RoActemra tocilizumab 200 mg/10mL concentrate for solution for infusion (Roche Germany) RoActemra tocilizumab 400 mg/20mL concentrate for solution for infusion (Roche Germany) These products are NOT registered in Australia and supply is authorised under an ex

​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th June 2021. Import and supply approved until: 31st August 2021 (now extended) ​ Imipramine 25mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 25mg not available. This shortage is expected to continue until Mid 2021. ​ Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 25 MG 100 TABLETS (LEADING PHARMA LLC) S19a​ Stock availability:

Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 10mg Tablets until 15th October 2021. Import and supply approved until: 15th October 2021 ​ Imipramine 10mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 10mg not available. This shortage is expected to continue until 31st July 2021. ​ Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 10 MG 100 TABLETS (LEADING PHARMA LLC) S19a​ PBS Listing: TBC ​ Order

​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020. ​ Bleomycin Injection is currently experiencing a shortage of supply in Australia. ​ Product: Bleomycin Injection 15 Units S19a ​ Stock availability: Stock is available now at Wholesalers Nationally. ​ Ordering Orders can be placed via Wholesalers Symbion and Central Healthcare Services (CHS) via the below PDE numbers. ​ Symbion PDE: 629103 CHS PDE: BLE

Pro PG will supply HPS Group selected Special Access Scheme (SAS) products until 31st July 2020. Pro PG is proud to align with HPS for the supply and will work with the individual sites to ensure SAS process is adhered to and products directly supplied Nationally in a timely manner. HPS Group are one of Australia’s leading providers of pharmacy services to private hospitals, cancer centres, and correctional facilities.